Looking At Pfizer's Recent Unusual Options Activity


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer.

Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 60% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $454,046 and 4, calls, for a total amount of $204,240.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $35.0 for Pfizer over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 9996.5 with a total volume of 7,888.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Pfizer's big money trades within a strike price range of $25.0 to $35.0 over the last 30 days.

Pfizer Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

SymbolPUT/CALLTrade TypeSentimentExp. DateStrike PriceTotal Trade PriceOpen InterestVolume
PFEPUTSWEEPBEARISH03/21/25$32.50$140.0K2.1K300
PFEPUTSWEEPBEARISH06/21/24$35.00$95.2K14.8K1
PFECALLSWEEPBEARISH11/03/23$31.00$93.0K17.8K896
PFEPUTSWEEPBEARISH03/15/24$32.50$84.8K17.6K266
PFECALLSWEEPBULLISH11/17/23$25.00$55.6K122100

Ready to win big? Discover the #1 strategy for trading options in today's unpredictable market... with potential gains of 44%, 125% and even 411% every month on average. Starting at only $1 a day. Click here now.

Where Is Pfizer Standing Right Now?

  • With a volume of 7,594,323, the price of PFE is up 0.07% at $30.58.
  • RSI indicators hint that the underlying stock may be approaching oversold.
  • Next earnings are expected to be released in 90 days.

What The Experts Say On Pfizer:

  • Morgan Stanley has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $39.
  • JP Morgan has decided to maintain their Neutral rating on Pfizer, which currently sits at a price target of $34.
  • Truist Securities has decided to maintain their Buy rating on Pfizer, which currently sits at a price target of $42.
  • BMO Capital has decided to maintain their Outperform rating on Pfizer, which currently sits at a price target of $33.
  • UBS downgraded its action to Neutral with a price target of $34

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: OptionsMarketsBZI-UOA